Skip to content

Clinical trials

Lymphoma, Large B-Cell, Diffuse trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Country / region: France Clear all

174 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20036
20044
20054
20061
20079
20083
20094
20103
20119
20128
20137
20143
20159
201610
20178
20187
201910
202010
202114
202213
202310
20246
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed92
Terminated29
Active, not recruiting23
Recruiting17
Unknown status9
Not yet recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lymphoma Study Association13
Novartis Pharmaceuticals11
Celgene9
European Organisation for Research and Treatment of Cancer - EORTC8
Genmab8
The Lymphoma Academic Research Organisation8
Hoffmann-La Roche6
Hospices Civils de Lyon6
Incyte Corporation5
Janssen Research & Development, LLC5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse174
Lymphoma, Non-Hodgkin50
Lymphoma, Follicular46
Lymphoma45
Lymphoma, Mantle-Cell29
Leukemia, Lymphocytic, Chronic, B-Cell28
Lymphoma, B-Cell, Marginal Zone24
Recurrence24
Lymphoma, B-Cell20
Multiple Myeloma17

Trials

Showing 1 to 25 of 174. Each trial links to its page on Pharma Observatory.

74 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.